Genus plc

2,392pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:GNSHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR 3.62%
Div yield 1.47%
ROE 45.88%
Biotechnology
Beta (5Y) 0.86
PE TTM 5.627
TSR TTM (1.50%)
Mkt cap £1.539B
ROIC 8.74%
SE Grade™
Value
Quality
Moat
Consensus
Reference
2,557p
6.89%
(70.40%)
Hold 8|12|5|11|9
2Q26
3Q26
4Q26
1Q27
Earnings per share£
27.18
29.33
32.23
34.94
12.69%
16.91%
19.78%
27.51%
Revenue£M
68.19
68.97
70.03
72.90
(2.46%)
(0.29%)
(3.10%)
3.84%
Peers (US$2.071B)
Cap (US$)
PE
2.709B
—
Capital
TTM
5Y
10Y
Leveragex
4.091
(0.058)
(0.053)
EBIT/Intx
1.177
0.074
0.082
Own earn%
127.17
48.56
33.13
Sh yield%
26.90
25.90
22.13
Owners
Insiders/Inst%
10.69
51.54
Short interest%
2.31
SBC / revenue%
4.85
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
4–10
$1 testx
0.2
Incr. ROIC%
2